NCT01563926View on ClinicalTrials.gov

Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

October 23, 2000

Primary Completion Date

October 10, 2002

Study Completion Date

October 10, 2002

Conditions
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenGenetic DisorderTurner Syndrome
Interventions
DRUG

somatropin

Dosed by individual needs as judged by the Investigator (trial physician). Injected subcutaneously (s.c./under the skin)

Trial Locations (6)

18101

Novo Nordisk Investigational Site, Afula

49202

Novo Nordisk Investigational Site, Petah Tikva

64293

Novo Nordisk Investigational Site, Tel Aviv

76100

Novo Nordisk Investigational Site, Rehovot

84101

Novo Nordisk Investigational Site, Beersheba

91240

Novo Nordisk Investigational Site, Jerusalem

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY